- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
BIO
ASX
Week ended 09 Oct 2026
Weekly Investor Report
Biome Australia Limited · Consumer Defensive · Packaged Foods
Latest close
0.405 AUD
-3.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 30.2% above the Trend Line and sits at 66.1% of its 52-week range. The latest completed week returned -3.6%, after a 11.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
53
out of 100
Latest Close
0.405 AUD
9 Oct 2026
1W Return
-3.6%
latest completed week
4W Return
11.0%
short-term follow-through
12W Return
62.0%
quarterly tape
Trend Breadth
3.8%
2 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.6%
Latest completed week; four-week move 11.0%.
Indicator stack
9/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 30.2% above the Trend Line and sits at 66.1% of its 52-week range. The latest completed week returned -3.6%, after a 11.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
9 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4712-week average 0.27
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.47Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.0% over four weeks, 62.0% over 12 weeks, and -16.5% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year2
Trend breadth3.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.49Latest activity-pressure read.
Pressure change27.7%Four-week change in activity pressure.
Leadership13.29Latest relative-leadership reading.
RS change1970.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Oct 2026
Financial statements through 30 Jun 2025
Field coverage 24%
Model confidence 10%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength95/100Blend of value, momentum, and quality. Underlying universe rank 6; rank 1 is best.
Value83/100Relative valuation strength. Underlying universe rank 18; rank 1 is best.
Quality82/100Profitability and accounting quality. Underlying universe rank 19; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 0/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- - Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 9 relevant articles.
5 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-20.6%Distance below the 52-week high.
13-week volatility8.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
17 Apr
15 May
12 Jun
10 Jul
7 Aug
4 Sep
9 Oct
Weeks higher10 of 2616 weeks finished lower.
Best week+26.9%Week of 5 Jun.
Worst week-10.8%Week of 1 May.
Latest week-3.6%Week of 9 Oct.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses8
Sharp losses8
Recent vol8.8%13-week weekly-return volatility.
Base vol8.3%52-week weekly-return volatility.
Up/down split20/30Count of positive and negative weeks in the 52-week window.
Average skew8.0% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Consumer Defensive
4-week rank10 / 59
Group average2.4%
Trend breadth28.8%
Trend28.8%active weekly trend signals
MD61.0%positive activity pressure
RS30.5%positive relative leadership
Four-week leaders
IndustryAU Packaged Foods
4-week rank5 / 24
Group average1.8%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.3%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis46/100Latest 12-week confirmation: trend 2/12, activity pressure 10/12, relative leadership 5/12.
Activity pressure 0.47; No reversal markers Factors85/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 15; Small Cap Core rank 28 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 9 relevant articles.
Biome Australia Reports FY26 Sales Revenue of $23.9 Million and Second Consecutive Net Profit Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 9 Oct 2026 | 0.405 AUD | -3.6% | 0.3111 AUD | 0.4272 AUD | 1.49 | 13.29 | 396.4K | On |
| 2 Oct 2026 | 0.42 AUD | 3.7% | 0.3104 AUD | 0.4255 AUD | 1.59 | 17.53 | 872.9K | On |
| 25 Sep 2026 | 0.405 AUD | -3.6% | 0.3101 AUD | 0.4237 AUD | 1.53 | 13.26 | 527.9K | Off |
| 18 Sep 2026 | 0.42 AUD | 15.1% | 0.3106 AUD | 0.422 AUD | 1.48 | 16.27 | 1.5M | Off |
| 11 Sep 2026 | 0.365 AUD | 2.8% | 0.3101 AUD | 0.4201 AUD | 1.17 | 0.64 | 1.1M | Off |
| 4 Sep 2026 | 0.355 AUD | 4.4% | 0.3116 AUD | 0.4186 AUD | 0.88 | -5.51 | 249.0K | Off |
| 28 Aug 2026 | 0.34 AUD | 25.9% | 0.3148 AUD | 0.4172 AUD | 0.71 | -11.10 | 345.4K | Off |
| 21 Aug 2026 | 0.27 AUD | -3.6% | 0.3184 AUD | 0.416 AUD | 0.50 | -29.88 | 73.0K | Off |
| 14 Aug 2026 | 0.28 AUD | -3.4% | 0.3241 AUD | 0.4151 AUD | 0.37 | -28.78 | 90.3K | Off |
| 7 Aug 2026 | 0.29 AUD | 3.6% | 0.3306 AUD | 0.4141 AUD | 0.19 | -28.38 | 202.0K | Off |
| 31 Jul 2026 | 0.28 AUD | 9.8% | 0.3344 AUD | 0.4132 AUD | -0.00 | -29.52 | 237.7K | Off |
| 24 Jul 2026 | 0.255 AUD | 2.0% | 0.3389 AUD | 0.4122 AUD | -0.12 | -35.15 | 301.9K | Off |
| 17 Jul 2026 | 0.25 AUD | -7.4% | 0.3448 AUD | 0.4111 AUD | -0.36 | -37.58 | 455.4K | Off |
| 10 Jul 2026 | 0.27 AUD | -5.3% | 0.3502 AUD | 0.4102 AUD | -0.53 | -33.54 | 154.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.